19F MRI in Healthy Children and Children With Mild Cystic Fibrosis Lung Disease
University of North Carolina, Chapel Hill · with Cystic Fibrosis Foundation, National Heart, Lung, and Blood Institute (NHLBI) · NCT06066723
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 6–17 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 15
- US sites recruiting
- 1
- Study start
- June 16, 2025
- Record last updated
- July 2, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study capitalizes on the emerging technology of 19F MRI, using conventional 'thermally' polarized perfluorinated gas (perfluoropropane, or PFP) mixed with oxygen and studied with magnetic resonance imaging (MRI) to visualize ventilation. This technique has not been studied in children.
Children and adolescents (6-17 years old) with cystic fibrosis (CF) who have normal spirometry will undergo 19F MRI with the inhalation of an inert contrast gas to study ventilation. Comparisons will be made to a cohort of healthy children (6-17 years old) who will perform the same measures. The primary outcome measure is the feasibility of conducting these studies in the pediatric population. Parallel performance of multiple breath nitrogen washout (MBW) and spirometry will be used to compare the sensitivity of these outcomes to the presence of mild lung disease in these children. Finally, the investigators will compare data obtained during standard breath holds with a novel "free-breathing" technique that will eliminate the need for breath holds during MRI acquisition.
Being studied: 19F MRI
Conditions: Cystic Fibrosis in Children
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 6-17 years old
- Non-smoker and non-vaper
- Cystic Fibrosis (CF) Group: must have a diagnosis of CF
- No use of supplemental oxygen
- They must be able to perform spirometry and have stable lung function (within 10% personal best in the last 6 months) and no exacerbations within the past 4 weeks
- Baseline forced expiratory volume in 1 second (FEV1) >80% with ratio of the forced expiratory volume in the first one second to the forced vital capacity of the lung (FEV1:FVC) ratio >0.7
Exclusion Criteria
- Healthy volunteers: with any history of chronic lung disease (i.e. asthma)
- Active or former smoker with less than 1 year of quitting
- Unable to undergo an MRI of the lungs and chest because of contraindications, including:
- Injury to the eye involving a metallic object
- Injury to the body involving a metallic object
- Presence of an implanted drug infusion device that is not MRI safe
- Bone growth of fusion simulator
- Presence of cochlear, otologic, or ear implant
- Shunt (spinal or intraventricular)
- Any implant held in place by magnet
- Claustrophobia
- Unable to tolerate the inhalation of the gas mixture
- Facial hair preventing a tight fit of the mask used in the study
- Pregnancy
- Changes in medication that may affect CF lung disease or lung function in the past 28 days, including experimental therapies
Recruiting US locations
University of North Carolina at Chapel Hill
Chapel Hill, NC 27514
Site contact: Jennifer L Goralski, MD · 919-445-0331 · jennifer_goralski@med.unc.edu
Study contacts (from the official record)
- Jennifer L Goralski, MD · 919-445-0331 · jennifer_goralski@med.unc.edu
- Caroline Flowers, BS · 984-974-2962 · caroline_flowers@med.unc.edu
Similar studies in North Carolina
All healthy volunteers studies in North Carolina →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Nalmefene Implant in Healthy Subjects
ReacX Pharmaceuticals, Inc.
- Location
- Morrisville, NC
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study
University of North Carolina, Chapel Hill
- Location
- Chapel Hill, NC + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteers
Breastfeeding Intervention to Prevent Obesity Among Children
University of North Carolina, Greensboro
- Location
- Greensboro, NC + 1 other US site
- Eligibility basics
- Ages 0 mo+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Charlotte, NC + 7 other US sites
- Eligibility basics
- Ages 12–55